Rothermundt, C.
von Rappard, J.
Eisen, T.
Escudier, B.
Grünwald, V.
Larkin, J.
McDermott, D.
Oldenburg, J.
Porta, C.
Rini, B.
Schmidinger, M.
Sternberg, C. N.
Putora, P. M.
Funding for this research was provided by:
Pfizer (Consultant Scientific Advisory Board, Grant and Personal Fees, Personal Fees Lecture and Advisor, Personal Fees, Grant and Personal Fees, Consulting and research funding, Lectures and consultancy, Honoraria)
GlaxoSmithKline Australia (Symposium funding – Personal fees, Personal Fees, Personal Fees Lecture and Advisor, Personal Fees, Lectures and consultancy)
Novartis (Symposium funding – Personal fees, Personal Fees, Personal Fees Lecture and Advisor, Honoraria)
AstraZeneca (Grant - Employment since 01/09/2014)
Bayer (Grant, Personal Fees Lecture, Personal Fees)
Roche (Personal Fees, Personal Fees, Lectures and consultancy)
Bristol-Myers Squibb Canada (Personal Fees, Personal Fees)
AVEO (Personal Fees TMG)
Astellas Pharma US (Personal Fees TMG, Grant, Lectures and consultancy)
Merck (Personal Fees)
Novartis Pharma (Grant, personal fees and non-financial support, Lectures and consultancy)
Pierre Fabre (Grant)